ICD-10 Code T56.7X4A: Toxic effect of beryllium

Key takeaways

ICD-10 code T56.7X4A is a billable diagnosis code for the toxic effect of beryllium with undetermined intent, initial encounter.

The 6th character 4 means the provider documented that intent could not be determined.

Accidental intent, character 1, is the default whenever the note says nothing about intent.

The 7th character A covers the initial encounter. Use D for subsequent visits and S for sequela.

Practice management software like Pabau keeps the provider note and the submitted claim on one patient record.

ICD-10 Code T56.7X4A is a billable ICD-10-CM diagnosis code for the toxic effect of beryllium with undetermined intent, initial encounter. The 6th character 4 records that the provider could not tell how the exposure happened.

That qualifier is one of the most frequently misapplied in the T56 family. Coders reach for undetermined when the record actually supports accidental, and the claim then contradicts the chart. This reference covers the code structure, the threshold for character 4, the 7th character logic, and every T56.7 variant.

ICD-10 Code T56.7X4A: definition, billable status, and clinical description

T56.7X4A is billable, so it can stand on its own as the diagnosis on a submitted claim. It is valid on HIPAA-covered transactions. The CMS ICD-10-CM tabular list carries it from October 1 of the applicable fiscal year.

The code belongs to category T56, toxic effects of metals. Its subcategory is T56.7, toxic effects of beryllium and its compounds.

Use ICD-10 Code T56.7X4A at the first visit when the provider cannot say whether the exposure was accidental, intentional, or an assault. Subsequent visits use T56.7X4D, and late effects use T56.7X4S. The intent qualifier on the claim has to match the one written in the note. Good claims and billing tools work from the same record the coder read.

Code structure breakdown: what each character in T56.7X4A means

ICD-10-CM codes for toxic effects follow a consistent positional logic. Understanding each character in ICD-10 Code T56.7X4A removes ambiguity when a coder needs to select among the related T56.7 variants.

The placeholder X at position 5 is a standard ICD-10-CM structural requirement. It fills that slot so the intent character sits in position 6 and the episode-of-care qualifier sits in position 7. Omitting the X produces an invalid code that payers will reject.

The same placeholder convention runs through Chapter 19, including sequela codes such as S06.813S.

What does undetermined intent mean?

Undetermined intent means the provider documented that they could not establish how the exposure happened. It is not a default. The ICD-10-CM Official Guidelines for Coding and Reporting set the rule in Section I.C.19. Accidental intent, character 1, is presumed when provider documentation does not specify. Character 4 applies only when the documentation states that intent cannot be determined.

This distinction matters for claim adjudication. Payers may ask for more documentation when undetermined intent is coded, because it signals an incomplete picture. Misapplying character 4 where character 1 belongs can trigger audits or secondary payer complications. The same intent character runs through the poisoning codes, as T44.902D shows.

• Use character 1 (T56.7X1A, accidental): the exposure was unintended and the note reflects that, or intent is not documented at all
• Use character 2 (T56.7X2A, intentional self-harm): the provider documents deliberate self-exposure with intent to harm
• Use character 3 (T56.7X3A, assault): another party intentionally exposed the patient
• Use character 4 (T56.7X4A, undetermined): the note states that intent cannot be determined from the available evidence

Here is the practical threshold. If a provider writes “unable to determine whether intentional or accidental,” character 4 is appropriate. If the note is silent on intent, default to character 1.

Initial encounter, subsequent encounter, and sequela: 7th character extension guide

The 7th character extension in ICD-10 Code T56.7X4A changes with each phase of the patient’s care. Assigning the wrong episode-of-care character is one of the most common coding errors for toxic-effect presentations.

“Initial encounter” does not mean only the very first visit a patient has ever had. It means the patient is receiving active treatment for the current episode. A patient transferred to another facility on day two of inpatient care is still in that phase.

Switch to D once the provider is managing healing and recovery rather than delivering acute intervention. Sequela coding works the same way in other Chapter 19 families, such as S52.133S.

Related codes in the T56.7 family: all intent and encounter variants

ICD-10 Code T56.7X4A is one of 12 codes in the T56.7 beryllium family. Each one pairs an intent character with an episode-of-care character. The table below lists all 12, including the sequela codes that shorter references leave out.

Parent category: T56 toxic effects of metals

T56.7X4A sits inside the broader T56 block, which covers toxic effects of metals. Reading the sibling codes is how you confirm the subcategory when the note names a specific metal. The same hierarchical logic runs through the whole T51-T65 block, including corrosion codes such as T32.84.

• T56.0: Toxic effects of lead and its compounds
• T56.1: Toxic effects of mercury and its compounds
• T56.2: Toxic effects of chromium and its compounds
• T56.3: Toxic effects of cadmium and its compounds
• T56.4: Toxic effects of copper and its compounds
• T56.5: Toxic effects of zinc and its compounds
• T56.6: Toxic effects of tin and its compounds
• T56.7: Toxic effects of beryllium and its compounds
• T56.81: Toxic effects of thallium
• T56.82: Toxic effects of gadolinium
• T56.89: Toxic effects of other metals
• T56.91: Toxic effects of unspecified metal

If documentation references metal exposure but does not specify beryllium, T56.91 is the fallback. Coding T56.7X4A without clear documentation of beryllium specifically is a specificity error that can surface during payer audits.

Clinical context: beryllium toxicity and occupational exposure

Beryllium is a lightweight metal used in aerospace, defense manufacturing, electronics, and nuclear work. Exposure happens mostly through inhaling beryllium dust or fumes on site. Accidental ingestion and skin contact are documented routes too. Occupational health practices and emergency departments serving industrial communities see T56.7X4A most often.

According to NIOSH beryllium hazard documentation, exposure can cause acute beryllium disease and chronic berylliosis. Berylliosis is a granulomatous lung condition that can surface years after the exposure. Acute toxic effect is coded under T56.7. Chronic berylliosis sequela takes T56.7X_S plus a second code for the lung condition.

• Acute beryllium disease: rapid-onset inflammation after high-level exposure, coded at the initial encounter with the applicable intent character
• Chronic berylliosis: progressive granulomatous disease, documented as a sequela with T56.7X_S plus J63.2 where it applies
• Beryllium sensitization: an immune response without overt disease, so the note should say whether an active toxic effect is present

Chronic cases move into long-term management, and the therapy is billed separately from the diagnosis. Breathing and respiratory muscle work is reported with G0237, so it often sits on the same claim run as the sequela code. Practices running that program need physical therapy software that keeps the session notes with the diagnosis.

Patients left with lasting functional limits are referred on for daily-living support. Those sessions carry the sequela code too, so an occupational therapy software record should show it against each visit.

Coding guidelines and documentation requirements

Per ICD-10-CM Official Guidelines Section I.C.19.e, toxic effects are coded from the T51-T65 range. Assign the toxic effect code first, then any additional codes for the manifestations the provider documented. For T56.7X4A that usually means the beryllium code as principal diagnosis at the initial encounter. Acute respiratory symptoms, skin manifestations, and other systemic effects follow it.

Maintaining HIPAA-compliant documentation practices alongside accurate intent coding reduces the risk of both payer audits and compliance exposure. The key documentation elements that support ICD-10 Code T56.7X4A over the accidental variant are:

• An explicit provider statement that intent cannot be determined from available history, police reports, or witness accounts
• Documentation of the investigation status (for example, “awaiting toxicology findings and incident report”)
• Notation of the route and estimated time of exposure where known
• Any external cause codes (from Y93/Y99) that apply to the occupational or circumstantial context

Look for the intent statement in the assessment section of the progress note, not in the history of present illness. Providers often describe causation in the HPI without making a determination. Only the assessment or clinical impression carries the qualifier that supports character 4, and structured medical documentation forms make it easier to find.

Occupational exposure files can end up in a legal request years later. The data protection practices covering health records apply to the whole case file.

How Pabau keeps the note and the claim in step

In a lot of practices the provider note lives in one system and the claim in another. The coder reads a PDF, types the code into billing software, and the thread between the two disappears.

Practice management software like Pabau keeps them on one record. Treatment notes, intake forms, photos, and attachments sit in the patient record, next to the appointment history and the invoice. When a payer questions a T56.7X4A claim, the assessment text that supports it is one click away.

Permissions and audit trails record who opened a file and what changed. For occupational exposure cases that may be reviewed years later, that history is worth as much as the code itself.

Keep clinical notes and claims in one place

Pabau, our all-in-one practice management system, stores treatment notes, forms, and encounter history on a single patient record. Your coders and billing team work from what the provider actually wrote.

Book a demo

Conclusion

Character 4 is a statement about the record, not about the patient. Assign it when the provider wrote that intent cannot be determined. Assign character 1 when the note simply says nothing.

Get that right and the claim matches the chart, which is the only defense that survives an audit. Get it wrong and you have built a paper trail that argues with your own clinician.

The rest is housekeeping. Keep the encounter character current as the patient moves from acute treatment into follow-up. Book a demo to see how Pabau keeps documentation and claims on one patient record.

Continue your research

Need a second look at respiratory therapy billing? G0237 covers the respiratory muscle strength training that chronic beryllium patients are often referred for.

Documenting lung function after an exposure? Cardiopulmonary exercise testing explains what the test measures and what belongs in the note afterwards.

Coding a chemical injury by body surface area? T32.91 shows how the extent-based corrosion codes are built and when they apply.

Unsure which encounter character a follow-up takes? S52.001E walks through a subsequent-encounter assignment in the fracture chapter.

Working with an unspecified diagnosis? R52 sets out how far an unspecified code can be pushed before payers push back.

Frequently asked questions